Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEX11B | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | TIMM17A | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
mRNA | CDC42SE1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | CHTOP | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | FAM63A | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | SCNM1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | CHCHD4 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |